v3.25.4
CONDENSED FINANCIAL INFORMATION OF THE PARENT COMPANY (Unaudited) (Details - Balance sheets) - USD ($)
Jan. 31, 2026
Jul. 31, 2025
ASSETS    
Cash $ 723,101 $ 2,405,352
Total Assets 2,690,261 3,145,971
LIABILITIES    
Total liabilities 101,342 159,054
Stockholders’ equity    
Common stock, $0.0001 par value, 100,000,000 shares authorized; 25,331,803 and 16,531,803 shares issued and outstanding as of January 31, 2026 and July 31, 2025, respectively $ 2,533 $ 1,653
Common stock, par value $ 0.0001 $ 0.0001
Common stock, shares authorized 100,000,000 100,000,000
Common stock, shares issued 25,331,803 16,531,803
Common stock, shares outstanding 25,331,803 16,531,803
Additional paid-in capital $ 6,132,633 $ 5,845,505
Accumulated deficit (3,530,856) (2,862,860)
Total stockholders’ equity 2,604,310 2,984,306
Total Liabilities and Stockholders’ Equity $ 2,690,261 $ 3,145,971
Series A Preferred Stock [Member]    
Stockholders’ equity    
Preferred stock, par value $ 0.0001 $ 0.0001
Preferred stock, shares authorized 80,000 80,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Preferred stock value $ 0 $ 0
Series B Preferred Stock [Member]    
Stockholders’ equity    
Preferred stock, par value $ 0.0001 $ 0.0001
Preferred stock, shares authorized 80,000 80,000
Preferred stock, shares issued 0 80,000
Preferred stock, shares outstanding 0 80,000
Preferred stock value $ 0 $ 8
Undesignated Preferred Stock [Member]    
Stockholders’ equity    
Preferred stock, par value $ 0.0001 $ 0.0001
Preferred stock, shares authorized 19,920,000 19,920,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Preferred stock value $ 0 $ 0
Consolidated Entities [Member]    
ASSETS    
Cash 294,584 2,177,414
Prepaid expense 117,699 39,373
Receivable from subsidiaries 1,847,584 497,584
Investment in subsidiaries 2,192,177 288,614
Total Assets 2,604,460 3,002,985
LIABILITIES    
Accounts payable and other accrued liabilities 150 18,679
Due to related parties 0 0
Total liabilities 150 18,679
Stockholders’ equity    
Common stock, $0.0001 par value, 100,000,000 shares authorized; 25,331,803 and 16,531,803 shares issued and outstanding as of January 31, 2026 and July 31, 2025, respectively 2,533 1,653
Additional paid-in capital 6,132,633 5,845,505
Accumulated deficit (3,530,856) (2,862,860)
Total stockholders’ equity 2,604,310 2,984,306
Total Liabilities and Stockholders’ Equity $ 2,604,460 $ 3,002,985